Vaccine News and Research

Latest Vaccine News and Research

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Announcing a new article publication for Zoonoses journal. In the context of two Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreaks involving local transmission and an international flight, the authors of this article used meta-transcriptome and multi-amplicon sequencing to successfully acquire the complete viral genome sequences from clinical samples with varying viral loads.

1 Feb 2024

Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years

Study shows that a single dose of typhoid conjugate vaccine provides over four years of protection against typhoid fever in Malawian children, proving effective across all age groups.

31 Jan 2024

New project aims to increase the EU's ability to combat flavivirus threats

A new project - FLAVIVACCINE - aims to increase the EU's ability to combat epidemic and pandemic viral threats both in Europe and around the world.

31 Jan 2024

New initiative aims to transform how Alzheimer's disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer's research, implementation science, and precision medicine.

31 Jan 2024

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Using a virus-like delivery particle made from DNA, researchers from MIT and the Ragon Institute of MGH, MIT, and Harvard have created a vaccine that can induce a strong antibody response against SARS-CoV-2.

30 Jan 2024

Learning from loss: US covid-19 experience charts path for future public health

Ahead of the 2024 US presidential election, The BMJ today launches a forward-looking series that highlights the lessons that can be learned from the US's covid-19 experience and the actions that are needed to prevent the loss of another million citizens in the next pandemic and improve and protect population health.

29 Jan 2024

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

A new scientific statement from the American Heart Association emphasizes the need to increase patients' and physicians' awareness of cerebral venous thrombosis (CVT) to improve the recognition of this condition and initiate prompt medical treatment.

29 Jan 2024

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

Rates of routine childhood vaccination hit a 10-year low in 2023. That, according to the Centers for Disease Control and Prevention, puts about 250,000 kindergartners at risk for measles, which often leads to hospitalization and can cause death.

29 Jan 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

Scientists at La Jolla Institute for Immunology (LJI) have found direct evidence that exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2. In fact, prior exposure to a common cold coronavirus appears to partially protect mice from lung damage during a subsequent SARS-CoV-2 infection.

27 Jan 2024

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

A valuable molecule sourced from the soapbark tree and used as a key ingredient in vaccines, has been replicated in an alternative plant host for the first time, opening unprecedented opportunities for the vaccine industry.

26 Jan 2024

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine's (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.

25 Jan 2024

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

The long-term protection offered by one dose of vaccine against yellow fever.

25 Jan 2024

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

A large cohort study in "JAMA Pediatrics" found no significant differences in neurodevelopmental rates between infants exposed to COVID-19 vaccines in-utero and those who were not, affirming the safety of maternal COVID-19 vaccination.

24 Jan 2024

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Researchers analyzed the toxicity concerns and advancements in mRNA therapeutics, focusing on their cellular toxicity, reactogenicity, and distribution, and discussed the challenges and benefits of mRNA research.

24 Jan 2024

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

A study in JAMA Network Open reveals that maternal COVID-19 vaccination provides similar antibody levels in preterm and full-term infants' cord blood, with higher doses leading to increased antibodies.

24 Jan 2024

Researchers secure $1.5 million grant to eliminate barriers from cervical cancer prevention

A research team from LSU LCMC Health Cancer Center has been awarded a $1.5 million grant to eliminate barriers from cervical cancer prevention. The five-year program combines a $1.2 million award from the American Cancer Society and $75,000 a year for five years investment from LSU Health New Orleans.

24 Jan 2024

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

The UK Health Security Agency (UKHSA) has today published its Pathogen Genomics Strategy, laying out a 5 year plan for the organization's role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

24 Jan 2024

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they themselves were not infected with the virus.

24 Jan 2024

Persistent presence of SARS-CoV-2 RNA found in long COVID patients

Researchers conduct blood digital transcriptomics to determine the persistence of SARS-CoV-2 RNA in patients with long COVID-19.

23 Jan 2024

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

23 Jan 2024

Previous
1
...
10
11
12
13
14
15
16
...
1093
Next

Vaccine News and Research

Latest Vaccine News and Research

New sequencing tool speeds up SARS-CoV-2 outbreak response and informs treatment

Evidence from Malawi: Typhoid conjugate vaccine provides protection for up to four years

New project aims to increase the EU's ability to combat flavivirus threats

New initiative aims to transform how Alzheimer's disease is diagnosed, treated across healthcare settings

New DNA-based vaccine can induce strong antibody response against SARS-CoV-2

Learning from loss: US covid-19 experience charts path for future public health

New scientific statement outlines recommendations for diagnosing, managing cerebral venous thrombosis

How fringe anti-science views infiltrated mainstream politics — and what it means in 2024

Prior exposure to common cold coronaviruses can train T cells to fight SARS-CoV-2

New study opens unprecedented opportunities for bioengineering vaccine adjuvants

Clinical study supports the long-lasting impacts of typhoid conjugate vaccine

Do yellow fever vaccines truly provide effective lifelong protection against the disease after a single dose?

Study confirms safety of COVID-19 vaccination during pregnancy for infant neurodevelopment

Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine

Maternal COVID-19 vaccination equally benefits preterm and full-term babies

Researchers secure $1.5 million grant to eliminate barriers from cervical cancer prevention

UKHSA unveils groundbreaking Pathogen Genomics Strategy for pandemic preparedness

Study finds three times the risk of respiratory distress in infants born to COVID-infected mothers

Persistent presence of SARS-CoV-2 RNA found in long COVID patients

Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Vaccine News and Research

Latest Vaccine News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in